Background: Egr1 and renin-angiotensin system(RAAS)are invlovled in DKD, but the relationship between them is unclear.

Methods: Egr1 and RAAS were detected in HFD/STZ-induced mice and HK-2 cells treated with TGF-β1. Then, RAAS expression was detected in HK-2 cells and mice with overexpression and knock-down of Egr1. The direct relationship between Egr1 and RAAS was explored via ChIP assay.

Results: We found increased levels of Egr1 and RAAS in the kidney cortices of DKD mice and TGF-β1-treated HK-2 cells. Overexpression or silencing of Egr1 in HK-2 cells and DKD mice could upregulate or downregulate the expression of RAAS. ChIP assays revealed that TGF-β1 induced Egr1 to bind to the RAAS promoter.

Conclusions: Our study provides strong evidence that Egr1 is a transcriptional activator of RAAS in DKD.
Disclosure

Y. Xue: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.